Picture of Poseida Therapeutics logo

PSTX Poseida Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Poseida Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-86.5-130-125-64-123
Depreciation
Non-Cash Items11.38.24-2.2918.311.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital9.475.6220.213.714.1
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-64.5-113-103-26.8-92.2
Capital Expenditures-5.16-16.9-2.63-3.92-3.07
Purchase of Fixed Assets
Other Investing Cash Flow Items-37.3-188225-19942.2
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-42.5-204222-20339.1
Financing Cash Flow Items4.593.830-1.45-0.494
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1643142.5210516.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash57.4-3.82122-125-36.9